Howard Horn sold $250K of Ultragenyx Pharmaceutical (RARE)

Executed Oct 13 2025, disclosed Oct 14 2025, 1 day later.

Value, as filed

$250K

7,942 sh × $31.51

Executed

Oct 13 2025

the trade date, as filed

Disclosed

Oct 14 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Howard Horn Chief Financial Officer profile →

Howard Horn (Chief Financial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $156K of RARE (4,698 sh × $33.13, as filed), executed Jul 1.

The name

RARE

Ultragenyx Pharmaceutical Inc. RARE · Healthcare · 28 filings in 24 months ticker →

Healthcare · Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Howard Horn in RARE

RARESALE Ultragenyx Pharmaceutical Inc. $108K
7,066 sh × $15.27
Exec Oct 15
Filed Oct 19 · 1:48 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $117K
4,696 sh × $24.92
Exec Aug 3
Filed Aug 4 · 3:13 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $156K
4,698 sh × $33.13
Exec Jul 1
Filed Jul 6 · 3:37 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $111K
4,653 sh × $23.77
Exec Jun 1
Filed Jun 1 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $117K
4,683 sh × $24.90
Exec May 1
Filed May 4 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $121K
5,290 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $112K
3,081 sh × $36.38
Exec Dec 10 2025
Filed Dec 11 2025 · 5:30 PM ET